BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mondelli MU. NKG2D and its ligands: key to immunotherapy of liver cancer? J Hepatol 2012;56:308-10. [PMID: 21798219 DOI: 10.1016/j.jhep.2011.07.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Prieto J, Melero I, Sangro B. Immunological landscape and immunotherapy of hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol. 2015;12:681-700. [PMID: 26484443 DOI: 10.1038/nrgastro.2015.173] [Cited by in Crossref: 313] [Cited by in F6Publishing: 314] [Article Influence: 44.7] [Reference Citation Analysis]
2 Qi F, Du X, Zhao Z, Zhang D, Huang M, Bai Y, Yang B, Qin W, Xia J. Tumor Mutation Burden-Associated LINC00638/miR-4732-3p/ULBP1 Axis Promotes Immune Escape via PD-L1 in Hepatocellular Carcinoma. Front Oncol 2021;11:729340. [PMID: 34568062 DOI: 10.3389/fonc.2021.729340] [Reference Citation Analysis]
3 Eheim A, Medrikova D, Herzig S. Immune cells and metabolic dysfunction. Semin Immunopathol. 2014;36:13-25. [PMID: 24212254 DOI: 10.1007/s00281-013-0403-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
4 Ruan GT, Xie HL, Zhu LC, Ge YZ, Yan L, Liao C, Gong YZ, Shi HP. Immune ULBP1 is Elevated in Colon Adenocarcinoma and Predicts Prognosis. Front Genet 2022;13:762514. [PMID: 35211154 DOI: 10.3389/fgene.2022.762514] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Min D, Lv XB, Wang X, Zhang B, Meng W, Yu F, Hu H. Downregulation of miR-302c and miR-520c by 1,25(OH)2D3 treatment enhances the susceptibility of tumour cells to natural killer cell-mediated cytotoxicity. Br J Cancer 2013;109:723-30. [PMID: 23820258 DOI: 10.1038/bjc.2013.337] [Cited by in Crossref: 44] [Cited by in F6Publishing: 45] [Article Influence: 4.9] [Reference Citation Analysis]
6 Gavlovsky PJ, Tonnerre P, Gérard N, Nedellec S, Daman AW, McFarland BJ, Charreau B. Alternative Splice Transcripts for MHC Class I-like MICA Encode Novel NKG2D Ligands with Agonist or Antagonist Functions. J Immunol 2016;197:736-46. [PMID: 27342847 DOI: 10.4049/jimmunol.1501416] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]